.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Covington
Johnson and Johnson
Chinese Patent Office
McKinsey
Baxter
UBS
Accenture
Citi
Federal Trade Commission

Generated: December 12, 2017

US Patents Corresponding to PCT: WO2009/098169


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Citius PharmsSUPRENZAphentermine hydrochlorideTABLET, ORALLY DISINTEGRATING;ORAL202088-001Jun 13, 2011DISCNNoNo► Subscribe► Subscribe► SubscribeY
Citius PharmsSUPRENZAphentermine hydrochlorideTABLET, ORALLY DISINTEGRATING;ORAL202088-002Jun 13, 2011DISCNNoNo► Subscribe► Subscribe► SubscribeY
Citius PharmsSUPRENZAphentermine hydrochlorideTABLET, ORALLY DISINTEGRATING;ORAL202088-003Mar 27, 2012DISCNNoNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist